Literature DB >> 19740742

Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex.

Sherly Mosessian1, Nuraly K Avliyakulov, David J Mulholland, Pinmanee Boontheung, Joseph A Loo, Hong Wu.   

Abstract

PTEN (phosphatase and tensin homolog deleted on chromosome 10) is well characterized for its role in antagonizing the phosphoinositide 3-kinase pathway. Previous studies using size-exclusion chromatography demonstrated PTEN recruitment into high molecular mass complexes and hypothesized that PTEN phosphorylation status and PDZ binding domain may be required for such complex formation. In this study, we set out to test the structural requirements for PTEN complex assembly and identify the component(s) of the PTEN complex(es). Our results demonstrated that the PTEN catalytic function and PDZ binding domain are not absolutely required for its complex formation. On the other hand, PTEN phosphorylation status has a significant impact on its complex assembly. Our results further demonstrate enrichment of the PTEN complex in nuclear lysates, suggesting a mechanism through which PTEN phosphorylation may regulate its complex assembly. These results prompted further characterization of other protein components within the PTEN complex(es). Using size-exclusion chromatography and two-dimensional difference gel electrophoresis followed by mass spectrometry analysis, we identified heterogeneous nuclear ribonucleoprotein C (hnRNP C) as a novel protein recruited to higher molecular mass fractions in the presence of PTEN. Further analysis indicates that endogenous hnRNP C and PTEN interact and co-localize within the nucleus, suggesting a potential role for PTEN, alongside hnRNP C, in RNA regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740742      PMCID: PMC2781571          DOI: 10.1074/jbc.M109.027995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Authors:  F Vazquez; S R Grossman; Y Takahashi; M V Rokas; N Nakamura; W R Sellers
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

4.  PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.

Authors:  L P Weng; J L Brown; C Eng
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

5.  Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.

Authors:  Y Wu; D Dowbenko; S Spencer; R Laura; J Lee; Q Gu; L A Lasky
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology.

Authors:  R Tonge; J Shaw; B Middleton; R Rowlinson; S Rayner; J Young; F Pognan; E Hawkins; I Currie; M Davison
Journal:  Proteomics       Date:  2001-03       Impact factor: 3.984

Review 7.  Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.

Authors:  I U Ali; L M Schriml; M Dean
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

8.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

9.  Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase.

Authors:  L P Ford; J M Suh; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

10.  Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.

Authors:  X Wu; K Hepner; S Castelino-Prabhu; D Do; M B Kaye; X J Yuan; J Wood; C Ross; C L Sawyers; Y E Whang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

View more
  14 in total

Review 1.  PTEN level in tumor suppression: how much is too little?

Authors:  Arkaitz Carracedo; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

2.  PTEN-Associated Complexes: An Overview.

Authors:  Sherly Mosessian; Hong Wu
Journal:  Curr Top Biochem Res       Date:  2010

3.  The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2.

Authors:  Ekaterina I Mokhonova; Nuraly K Avliyakulov; Irina Kramerova; Elena Kudryashova; Michael J Haykinson; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2015-02-20       Impact factor: 6.150

4.  C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.

Authors:  Nuraly K Avliyakulov; Kavitha S Rajavel; Khanh Minh T Le; Lea Guo; Leili Mirsadraei; William H Yong; Linda M Liau; Sichen Li; Albert Lai; Phioanh L Nghiemphu; Timothy F Cloughesy; Michael Linetsky; Michael J Haykinson; Whitney B Pope
Journal:  J Neurooncol       Date:  2014-01-29       Impact factor: 4.130

5.  Determining PTEN functional status by network component deduced transcription factor activities.

Authors:  Linh M Tran; Chun-Ju Chang; Seema Plaisier; Shumin Wu; Julie Dang; Paul S Mischel; James C Liao; Thomas G Graeber; Hong Wu
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

6.  The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells.

Authors:  Jia Wu; Tian-Hui Pan; Song Xu; Li-Tao Jia; Lin-Lin Zhu; Jian-Shan Mao; Yong-Liang Zhu; Jian-Ting Cai
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

7.  Novel Cell and Tissue Acquisition System (CTAS): microdissection of live and frozen brain tissues.

Authors:  Lili C Kudo; Nancy Vi; Zhongcai Ma; Tony Fields; Nuraly K Avliyakulov; Michael J Haykinson; Anatol Bragin; Stanislav L Karsten
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

8.  Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.

Authors:  Marlena S Fejzo; Lee Anderson; Erika M von Euw; Ondrej Kalous; Nuraly K Avliyakulov; Michael J Haykinson; Gottfried E Konecny; Richard S Finn; Dennis J Slamon
Journal:  Int J Mol Sci       Date:  2013-02-01       Impact factor: 5.923

9.  Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.

Authors:  Thomas H Beckham; Joseph C Cheng; Ping Lu; S Tucker Marrison; James S Norris; Xiang Liu
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

10.  Proteomic identification of mitochondrial targets of arginase in human breast cancer.

Authors:  Rajan Singh; Nuraly K Avliyakulov; Melissa Braga; Michael J Haykinson; Luis Martinez; Vikash Singh; Meher Parveen; Gautam Chaudhuri; Shehla Pervin
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.